![]() ![]() This brings H1's total funding to $176.9M to date. H1 is backed by Altimeter Capital, Menlo Ventures, IVP, Lux Capital, Goldman Sachs Asset Management, Lead Edge Capital, Novartis DRX, Flex Capital, ClearPoint Investment, and others. The company raised $100M in Series C round on Nov 16, 2021. H1, a startup pulling together information on healthcare professionals, recently closed a 100 million funding round led by Altimeter Capital. H1’s platform comprises over 8 million researcher, physician, pharmacist, nurse, and administrator profiles across 70 countries, 16,000 health care organizations, 160 million peer-reviewed publications (and citation counts), 350,000 clinical trials, 2 billion procedures, 3 billion diagnoses, 700 medical societies. an AI data analytics platform for the healthcare. H1's platform helps life sciences companies, hospitals, academic medical centers and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organizations. There has been an explosion of interest in the growth capital market in recent years, with numerous new investors raising. and others Data analytics company Global Data PLC filed a breach of contract claim on Aug. H1 has built the premier healthcare data network for Healthcare Providers (HCPs), searching scholarly data and medical claims data to surface the most relevant researchers or clinicians given any criteria. The company is headquartered in New York, New York. H1 was founded in 2017 by Ariel Katz and Ian SaxIan Sax. NEW YORK, Ma(GLOBE NEWSWIRE) - H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of. We don’t sell to sales and marketing arms at pharmaceutical companies, he says. H1 enables industry, healthcare organizations, and healthcare professionals to connect with each other like never before. H1 Insights has built certain rules on how its database should be used, which Katz hopes will limit abuse. H1 is the first company to arm healthcare and life science companies with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases. Global Real Estate Outlook 2023: Summary.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |